April 19, 2024
Market Now
Hanmi Pharma’s Q3 operating income down 61.5% to W13.5b
[DISCLOSURE] Hanmi Pharmaceutical (128940) reported on Oct. 27 that its operating profit in the third quarter slumped 61.5 percent to 13.7 billion won (US$12.03 million) on-year.
The revenue fell 18.1 percent to 219.7 billion won and net profit turned to black at 6.3 billion won from the same period last year.
(theinvestor@heraldcorp.com)
The revenue fell 18.1 percent to 219.7 billion won and net profit turned to black at 6.3 billion won from the same period last year.
(theinvestor@heraldcorp.com)
